Indian pharmaceutical giant Wockhardt is currently in merger talks. The company, known for its wide range of generic and branded medications, has been facing challenges in recent months. Sources close to the negotiations suggest that Wockhardt is {attracting interest from|being courted by both domestic and international firms. A final decision is a